Arbutus Biopharma 8K Filing
Arbutus Biopharma Corp files 8K with SEC, disclosing changes in leadership and compensation. The filing also includes financial statements and exhibits.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.